HWG Holdings’s Biogen BIIB Stock Holding History

HWG Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,400	Closed	-$392K	–	132
2021 Q1	$392K	Hold	1,400	–	–	0.2%	45
2020 Q4	$343K	Buy	+1,400	New	+$361K	0.17%	61

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HWG Holdings's BIIB Position: Q4 2020 in Review

HWG Holdings sold out of Biogen (BIIB) in Q4 2020, closing a stake of 145 shares — an estimated $37.4K sold.

HWG Holdings first reported a position in BIIB in Q4 2019 and held it in 3 quarters. The position peaked at $47K in Q4 2019. 1,061 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

HWG Holdings reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
HWG Holdings sold 145 Biogen shares in Q4 2020, an estimated $37.4K.
HWG Holdings first reported a position in Biogen in Q4 2019 and held it in 3 quarters.
HWG Holdings's Biogen position peaked at $47K in Q4 2019.
1,061 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on HWG Holdings's 13F filing for Q4 2020, filed 20 Jan 2021.